ArticleTherapeutic advances in infectious disease
Treatment success and associated factors among drug-susceptible tuberculosis patients in Teso region, Uganda: a retrospective study.
Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Uganda is among the 30 high tuberculosis (TB) burden countries, and still grapples with a suboptimal treatment success rate (the sum of cured and treatment completion), which stands at 89.1% for people living with HIV and 91.2% for those without HIV. The Teso region, one of the high TB burden regions in the country, has consistently had a lower treatment success rate (TSR). Objectives: To determine the treatment success and associated factors among drug-susceptible TB individuals in the Teso region, Uganda. Design: This retrospective study was conducted in the five (5) largest TB diagnostic units in the Teso region of Northeastern Uganda from 1st March 2025 to 28th March 2025. Methods: Data were collected from the health facility's TB treatment register. The primary outcome was treatment success. Data were analyzed using Stata statistical software, version 15.0, and summarized into proportions and frequencies. Modified Poisson regression analysis was conducted to determine factors associated with treatment success and reported as adjusted prevalence ratios (aPR). A Results: Data from 1009 individuals were included in the analysis; the median age was 45 years, with an interquartile range of (28-60). The majority of the individuals, 48.1% ( Conclusion: In this study, being female was associated with higher treatment success, while being older than 49 years and having HIV were associated with lower treatment success. This calls for early screening and strengthening TB preventive therapy among the people living with HIV, peer-to-peer support among the elderly for treatment adherence to improve TSR, and to achieve the goal of eradicating TB by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.